Search
Now showing items 1-10 of 39
Pcsk9 Inhibition And Inflammation: A Narrative Review
(2019)
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality despite excellent pharmacological and revascularization approaches. Low-density lipoproteins (LDL) are undoubtedly the most ...
Cardiac Amyloidosis: Recent Advances In The Diagnosis And Therapy
(2019)
Cardiac amyloidosis (CA) is a progressive cardiomyopathy in which misfolded endogenous proteins form amyloid fibrils that deposit in the heart as well as kidneys, liver, gastrointestinal tract and soft tissues. The most ...
Snapshot Evaluation Of Heart Failure In Turkey: Baseline Characteristics Of Selfie-Tr
(2019)
Objective: Heart failure (HF) is an important health issue of the 21st century and the prevalence in Turkey has been reported as 2.9%. A national profile, frequency data, characteristics of different phenotypes, and risk ...
2019 Turkish Hypertension Consensus Report
(2019)
The Turkish Hypertension Consensus Report was prepared for the first time in 2015 to adapt the European and American international guidelines to our clinical practice and to create a practical report that could be a basic ...
Effects Of Inspiratory Muscle Training In Patients With Heart Failure
(W B Saunders Co Ltd, 2011)
Aim: To investigate the effects of inspiratory muscle training (IMT) on functional capacity and balance, respiratory and peripheral muscle strength, pulmonary function, dyspnea, fatigue, depression, and quality of life in ...
Current Practice In Identifying And Treating Cardiovascular Risk, With A Focus On Residual Risk Associated With Atherogenic Dyslipidaemia
(Oxford Univ Press, 2016)
A panel of European experts on lipids and cardiovascular disease discussed clinical approaches to managing cardiovascular risk in clinical practice, including residual cardiovascular risk associated with lipid abnormalities, ...
İleri Evre Kalp Yetersizliği ve Mekanik Destek Cihazlarının Geleceği:Kardiyoloji ve Kalp Damar Cerrahisi Uzlaşı Raporu
(Baycinar Medical Publ-Baycinar Tibbi Yayincilik, 2016)
Heart failure is a progressive disease. A considerable portion of patients reach an advanced or terminal phase later or sooner, despite all of the developments in diagnosis, management, and follow-up and alternatives which ...